Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
US Department of Justice
Deloitte
US Army
Merck

Generated: July 22, 2019

DrugPatentWatch Database Preview

Agalsidase beta - Biologic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for agalsidase beta
Pharmacology for agalsidase beta
Ingredient-typealpha-Glucosidases

US Patents for agalsidase beta

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 001 2003-04-24 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 001 2003-04-24 ➤ Try a Free Trial CureVac AG (Tubingen, DE) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 001 2003-04-24 ➤ Try a Free Trial ALEXION PHARMACEUTICALS, INC. (New Haven, CT) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 001 2003-04-24 ➤ Try a Free Trial Protalix Ltd. (Carmiel, IL) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 001 2003-04-24 ➤ Try a Free Trial Mount Sinai School of Medicine of the City of New York (New York, NY) ➤ Try a Free Trial RX Orphan company
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 001 2003-04-24 ➤ Try a Free Trial Momenta Pharmaceuticals, Inc. (Cambridge, MA) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 001 2003-04-24 ➤ Try a Free Trial Cell Therapeutics, Inc. (Seattle, WA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patents for agalsidase beta

Supplementary Protection Certificates for agalsidase beta

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0627 Netherlands ➤ Try a Free Trial PRODUCT NAME: METHOD FOR PRODUCING SECRETED PROTIENS; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010803
2013000092 Germany ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE BETA; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010803
2013 00060 Denmark ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE BETA; REG. NO/DATE: EU/1/01/188/001-003 20010803
/2013 Austria ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE BETA; REGISTRATION NO/DATE: EU/1/01/188/001-003 20010803
2010 00020 Denmark ➤ Try a Free Trial
1942189/01 Switzerland ➤ Try a Free Trial FORMER OWNER: MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, US
C0064 France ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE BETA; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010807
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Deloitte
Baxter
Chinese Patent Office
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.